CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope
2019
AbstractPatients with non-Hodgkin lymphomas (NHLs) resistant to standard therapies have a dismal prognosis. The outcome is even poorer in patients relapsing after autologous stem cell transplantation. Most of these patients do not qualify for an allogeneic hematopoietic cell transplantation (HCT) du
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
39
References
15
Citations
NaN
KQI